Fulcrum Therapeutics Inc.
06/25/2026 | Press release | Distributed by Public on 06/25/2026 14:32
Proxy Results (Form 8-K)
| Item 5.07 |
Submission of Matters to a Vote of Security Holders. |
The following is a summary of the matters voted on at the 2026 annual meeting of stockholders of Fulcrum Therapeutics, Inc., or Fulcrum, held on June 24, 2026, or the Annual Meeting.
| a) |
Fulcrum's stockholders elected Sonja Banks, Alan Ezekowitz, and Colin Hill as class I directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2029 and each until her or his respective successor has been duly elected and qualified or until her or his earlier death, resignation or removal. The results of the stockholders' vote with respect to the election of the three Class I directors are as follows: |
|
Name |
Votes For |
Votes Withheld |
Broker Non-Votes |
|||||||||
|
Sonja Banks |
43,187,717 | 10,601,385 | 5,062,117 | |||||||||
|
Alan Ezekowitz |
52,317,282 | 1,471,820 | 5,062,117 | |||||||||
|
Colin Hill |
52,363,595 | 1,425,507 | 5,062,117 | |||||||||
| b) |
Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers. The results of the stockholders' vote with respect to such vote are as follows: |
|
Votes For |
Votes Against |
Abstain |
Broker |
|||
| 50,735,617 | 3,026,397 | 27,088 | 5,062,117 |
| d) |
Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the stockholders' vote with respect to such ratification are as follows: |
|
Votes For |
Votes Against |
Abstain |
Broker |
|||
| 58,793,645 | 36,178 | 21,396 | 0 |
Fulcrum Therapeutics Inc. published this content on June 25, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 25, 2026 at 20:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]